Navigation Links
YM BioSciences Reports Fiscal First Quarter 2011 Operational and Financial Results
Date:11/11/2010

ew product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that nimotuzumab will continue to demonstrate a competitive safety profile in ongoing and future clinical trials; that our JAK1/JAK2 inhibitor CYT387 and our VDA small molecule CYT997 will generate positive efficacy and safety data in future clinical trials; that YM and its various partners will complete their respective clinical trials within the timelines communicated in this release. Except as required by applicable securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Summary financial statements attached:YM BIOSCIENCES INC.
Interim Consolidated Balance Sheets
(Expressed in Canadian dollars, unless otherwise noted) September 30,  June 30, 2010 2010 (Unaudited)   Assets Current assets:   Cash and cash equivalents
$  15,095,919 $
9,460,141   Short-term deposits
25,073,158
26,184,991   Accounts receivable
,007
,184   Prepaid expenses
24,428
237,962 40,459,512
46,044,278 Property and equipment
28,855
84,775 Intangible asset
,518,7
,645,714 $
51,107,077 $
57,774,767 Liabilities and Shareholders' Equity Current liabilities:   Accounts payable
$ 693,188 $
99,277   Accrued liabilities
2,729,655
2,085,824   Deferred revenue
594,072
,523,916 4,016,915
4,309,017 Deferred revenue
2,277,27
,650,909 Shareholders' equity:   Share capital
203,522,4
'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. YM BIOSCIENCES REPORTS SIGNIFICANT RESPONSE RATES IN ANEMIA, SPLENOMEGALY, AND CONSTITUTIONAL SYMPTOMS FROM THE PHASE I/II TRIAL OF ITS JAK1/JAK2 INHIBITOR, CYT387, IN MYELOFIBROSIS
2. Regado Biosciences Awarded Three Grants from the Federal Government to Advance Research of Lead Programs
3. Sangamo BioSciences Awarded Grants for the Development of Four ZFP Therapeutic® Programs
4. Ardea Biosciences Awarded a $733,438 Grant from the U.S. Government Under the Patient Protection and Affordable Care Act
5. X-BODY BioSciences Awarded Grant for Therapeutic Discovery Project Targeting Metastatic Tumor Stem Cells
6. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
7. Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City
8. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
9. Sangamo BioSciences Announces Third Quarter 2010 Conference Call and Webcast
10. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
11. Cell Biosciences to Acquire Convergent Bioscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Just the characterization of being a new ... does not guarantee immediate acceptance. In particular, a ... prior failures is often met with significant skepticism. ... irony that is often an unappreciated aspect of scientific ... Asymmetrex has found that building acceptance of its ...
(Date:5/25/2015)... 2015 Where is the universe expanding ... "The honest answer is that nobody is entirely sure." ... throughout the month of June, starting with the ULI ... future-proofing to top tech trends. And one of the ... the universe is expanding to. According to Einstein’s theory ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Phenome Networks, ... software provider, announced the availability, beginning May 31st, of ... version of Phenome One solidifies Phenome Networks’ lead in ... supporting a simple and intuitive breeding workflow based on ... ability to customize field design, and more. The new ...
(Date:5/22/2015)... DALLAS , May 22, 2015 ... Market by Product (1D & 2D Gel Electrophoresis, Agarose ... CGE, MEKC, Reagents, Informatics), by Application & by End ... the Electrophoresis Market is expected to reach around $1.98 ... the forecast period 2015 to 2020. ...
Breaking Biology Technology:In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 2In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 3Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 2Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 3Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 2Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 3Electrophoresis Market Worth $1.98 Billion by 2020 2Electrophoresis Market Worth $1.98 Billion by 2020 3Electrophoresis Market Worth $1.98 Billion by 2020 4
... ROCKVILLE, Md., Oct 30 Novavax, Inc. (Nasdaq: NVAX ... quarter financial results in a press release to be issued ... The Company will hold an investor conference call to discuss ... November 6, 2009. The call will be hosted by Novavax ...
... , ORANGEBURG, S.C., Oct. 30 Zeus, Inc., a ... acquisition of AS9100 certification for aerospace applications. The standard ... it defines quality and management requirements. , This certification ... the aerospace industry. The company is also working directly ...
... SHANGHAI, Oct. 30 /PRNewswire-Asia-FirstCall/ -- China-Biotics, ... leading Chinese firm,specializing in the manufacture, research, development, ... appointment of Dr.,Tom Gu as Vice President, effective ... will,oversee the development of China Biotics, probiotics products ...
Cached Biology Technology:Novavax Announces Release Date of 2009 Third Quarter Financial Results and Investor Conference Call 2Zeus Increases Its Presence in Aerospace Industry with AS9100 Certification 2China-Biotics, Inc. Appoints New Vice President 2China-Biotics, Inc. Appoints New Vice President 3
(Date:5/19/2015)... Sweden , May 18, 2015 ... fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one ... from June until and including Q3 2015 and the sensors ... . Communicated order values for 2015 hereby amount to ... for Q1 2015 of 140 MSEK and a number of ...
(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
(Date:5/8/2015)... SAN JOSE, Calif. , May 8, 2015 ... human interface solutions, today announced that members of the executive ... J.P. Morgan 43rd Annual Technology, Media and Telecom Conference ... Westin Waterfront Hotel in Boston, MA ... Date: May 27, 2015 Time: 2:45pm ET Location: The New ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2
... release is available in Spanish . The ... other European centres, are taking part in a project to discover ... into leukaemia. In the work, patients from 19 hospitals in the ... were analysed, as well as from England, Italy, Sweden and Germany. ...
... University of Navarra, the Polytechnic University of Madrid (CBGP), ... the Valencian Institute of Agricultural Research have managed to ... in the olive tree. The study, included in the ... first sequencing of the genome of a pathogenic bacteria ...
... June 1, 2010 Making food choices based on television ... new study comparing the nutritional content of food choices influenced ... of the Journal of the American Dietetic Association . ... of advertised foods would contain 25 times the recommended servings ...
Cached Biology News:Genome of bacteria responsible for tuberculosis of olive tree sequenced 2TV food advertisements promote imbalanced diets 2
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The version upgrade allows upgrade of an established version of...
... ,High Quality, Functionally-Validated, Ion Channel Cell Lines ... having a critical role in nerve and ... function in pain, CNS and the heart. ... investigated in therapeutic areas, such as neuropathic ...
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
... monoclonal antibody raised against a ... Immunogen: TOPORS (NP_005793, ... partial recombinant protein with GST ... Number: NM_005802 ...
Biology Products: